Zinc transporter 8 autoantibodies assessment in daily practice.

@article{Hussein2017ZincT8,
  title={Zinc transporter 8 autoantibodies assessment in daily practice.},
  author={Hala IM Hussein and Fidaa Ibrahim and Eugene Sobngwi and Jean François Gautier and Philippe Boudou},
  journal={Clinical biochemistry},
  year={2017},
  volume={50 1-2},
  pages={94-96}
}
OBJECTIVES Zinc transporter 8 (ZnT8) is specifically expressed in the pancreatic β-cell and is more restricted in its tissue distribution than other auto-antigens as glutamic acid decarboxylase 65 (GAD65) and insulinoma-associated antigen-2 (IA2). ZnT8 autoantibodies (ZnT8A) assessment allows identifying rapid progression to clinical onset of the disease. We evaluated the prevalence of ZnT8A in adults of different ethnic and phenotypic groups and analyzed its potential utility as additional… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 14 references

Belgian Diabetes Registry. Contribution of antibodies against IA-2 and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age. Diabetes Care 2011;34:1760–65

I Vermeulen, I Weets, +9 authors FK Gorus
2011
View 1 Excerpt

Similar Papers

Loading similar papers…